Free Trial

DexCom (DXCM) Earnings Date, Estimates & Call Transcripts

DexCom logo
$75.24 +0.36 (+0.48%)
(As of 11/20/2024 ET)
Get DexCom Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DexCom and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DXCM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DXCM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DexCom Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243$0.25$0.33$0.28
Q2 20243$0.34$0.45$0.39
Q3 20243$0.39$0.44$0.41
Q4 20243$0.42$0.53$0.47
FY 202412$1.40$1.75$1.56
Q1 20253$0.29$0.39$0.35
Q2 20253$0.47$0.52$0.49
Q3 20252$0.52$0.58$0.55
Q4 20252$0.66$0.69$0.68
FY 202510$1.94$2.18$2.07

DexCom Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/13/2025
(Estimated)
------- 
7/25/2024Q2 2024$0.39$0.43+$0.04$0.51$1.04B$1.00B          
4/25/2024Q1 2024$0.27$0.32+$0.05$0.28$911.20M$921.00M        
2/8/2024Q4 2023$0.43$0.50+$0.07$0.38$1.02B$1.03B          
10/26/2023Q3 2023$0.34$0.50+$0.16$0.71$939.64M$975.00M          
7/27/2023Q2 2023$0.22$0.34+$0.12$0.40$841.16M$871.30M          
4/27/2023Q1 2023$0.15$0.17+$0.02$0.22$720.52M$7.45B        
2/9/2023Q4 2022$0.26$0.34+$0.08$0.46$814.52M$815.20M          

DexCom Earnings - Frequently Asked Questions

DexCom has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on DXCM's earnings history.

DexCom updated its FY 2024 earnings guidance on Thursday, October, 24th. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

DexCom (NASDAQ:DXCM) has a recorded annual revenue of $3.95 billion.

DexCom (NASDAQ:DXCM) has a recorded net income of $541.50 million. DXCM has generated $1.67 earnings per share over the last four quarters.

DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 45.05 and a forward price-to-earnings ratio of 44.00. The price/earnings-to-growth ratio is 2.33.

DexCom's earnings are expected to grow from $1.71 per share to $2.02 per share in the next year, which is a 18.13% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:DXCM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners